Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/14/2025

Anaphylaxis Diagnosis and Management

Clinical Presentation and Pathophysiology

  • The American Academy of Allergy, Asthma, and Immunology recommends recognizing that a type I hypersensitivity reaction involves Immunoglobulin E (IgE) antibodies, which is the correct mechanism for food-induced anaphylaxis presenting with shortness of breath, wheezing, and generalized body rash after allergen ingestion 1
  • Respiratory symptoms, such as wheezing, dyspnea, and throat tightness, occur in up to 70% of anaphylaxis cases, according to the American Academy of Allergy, Asthma, and Immunology 2
  • Gastrointestinal symptoms, such as vomiting, diarrhea, and abdominal pain, occur in up to 40% of anaphylaxis cases, as reported by the American Academy of Allergy, Asthma, and Immunology 2
  • Cardiovascular symptoms, such as hypotension and tachycardia, occur in up to 35% of anaphylaxis cases, according to the American Academy of Allergy, Asthma, and Immunology 2

Emergency Management

  • The American Heart Association recommends administering epinephrine immediately as the first-line treatment for anaphylaxis, with a dose of 0.3 mg for individuals over 25 kg, via autoinjector or 1:1,000 solution intramuscularly in the anterolateral thigh 3
  • The American Academy of Pediatrics suggests that epinephrine doses may need to be repeated every 5-15 minutes if symptoms persist, as part of the emergency management of anaphylaxis 5
  • The American College of Allergy, Asthma, and Immunology recommends administering a bronchodilator, such as albuterol, and providing supplemental oxygen therapy if respiratory symptoms are present, as adjunctive treatments for anaphylaxis 5

Monitoring and Observation

  • The American Academy of Emergency Medicine advises observing the patient for at least 4-6 hours after treatment, as biphasic reactions can occur in 1-20% of anaphylaxis cases, and monitoring for recurrence of symptoms, which may develop up to 72 hours after the initial reaction 2
  • The American College of Allergy, Asthma, and Immunology recommends being vigilant for signs of persistent or worsening respiratory distress or cardiovascular compromise, as part of the monitoring and observation of anaphylaxis patients 2

Risk Factors for Severe Reactions

  • The American Thoracic Society notes that asthma is a significant risk factor for fatal food-induced anaphylaxis, especially in adolescents, and that previous severe reactions may indicate higher risk, though severity of past reactions does not always predict future reaction severity 1
  • The American Academy of Allergy, Asthma, and Immunology reports that peanuts and tree nuts cause the majority of fatalities from food-induced anaphylaxis, and that delayed administration of epinephrine increases mortality risk 2

Discharge Planning

  • The American Academy of Pediatrics recommends prescribing two doses of epinephrine autoinjector for the patient to carry at all times, creating an anaphylaxis emergency action plan, and arranging follow-up evaluation with an allergist-immunologist, as part of the discharge planning for anaphylaxis patients 4
  • The American College of Allergy, Asthma, and Immunology suggests educating patients about strict avoidance of peanuts and potential cross-reactive foods, and warning about potential for accidental exposures, as part of the discharge planning for anaphylaxis patients 6

Long-Term Considerations

  • The American Academy of Allergy, Asthma, and Immunology notes that peanut allergy is usually persistent, with only about 20% of affected individuals outgrowing it, and that patients with peanut allergy have a high likelihood of sensitization to other tree nuts, though clinical reactivity to multiple nuts is lower 6
  • The American College of Allergy, Asthma, and Immunology reports that allergen-specific immunotherapy is being investigated but is not currently recommended as standard treatment for anaphylaxis 7